HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.056887v1 50/1/2    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, A. M. Search for Related Content PubMed PubMed Citation Articles by Wu, A. M.

Antibodies and Antimatter: The Resurgence of Immuno-PET

David Geffen School of Medicine at UCLA
Los Angeles, California

Correspondence: For correspondence or reprints contact: Anna M. Wu, Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095-1770. E-mail: awu{at}mednet.ucla.edu

ABSTRACT

The completion of the human genome, coupled with parallel major research efforts in proteomics and systems biology, has led to a flood of information on the roles of individual genes and proteins in normal physiologic processes and their disruptions in disease. In practical terms, this information has opened the door to increasingly targeted therapies as specific molecular markers are identified and validated. The ongoing transition from empiric to molecular medicine has engendered a need for corresponding molecular diagnostics, including noninvasive molecular imaging. Convergence of knowledge regarding key biomarkers that define normal biologic processes and disease with protein and imaging technology makes this an opportune time to revisit the combination of antibodies and PET, or immuno-PET.

Key Words: molecular imaging • PET • radioimmunoimaging • antibodies • biomarker imaging • immunoPET

FOOTNOTES

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]  

This article has been cited by other articles:

				P. K.E. Borjesson, Y. W.S. Jauw, R. de Bree, J. C. Roos, J. A. Castelijns, C. R. Leemans, G. A.M.S. van Dongen, and R. Boellaard Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients J. Nucl. Med., November 1, 2009; 50(11): 1828 - 1836. [Abstract] [Full Text] [PDF]

				S. Nimmagadda, M. Pullambhatla, and M. G. Pomper Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CT J. Nucl. Med., July 1, 2009; 50(7): 1124 - 1130. [Abstract] [Full Text] [PDF]